Song, C.W.; Kim, H.; Cho, H.; Kim, M.-S.; Paek, S.-H.; Park, H.-J.; Griffin, R.J.; Terezakis, S.; Cho, L.C.
HIF-1α Inhibition Improves Anti-Tumor Immunity and Promotes the Efficacy of Stereotactic Ablative Radiotherapy (SABR). Cancers 2022, 14, 3273.
https://doi.org/10.3390/cancers14133273
AMA Style
Song CW, Kim H, Cho H, Kim M-S, Paek S-H, Park H-J, Griffin RJ, Terezakis S, Cho LC.
HIF-1α Inhibition Improves Anti-Tumor Immunity and Promotes the Efficacy of Stereotactic Ablative Radiotherapy (SABR). Cancers. 2022; 14(13):3273.
https://doi.org/10.3390/cancers14133273
Chicago/Turabian Style
Song, Chang W., Hyunkyung Kim, Haeun Cho, Mi-Sook Kim, Sun-Ha Paek, Heon-Joo Park, Robert J. Griffin, Stephanie Terezakis, and Lawrence Chinsoo Cho.
2022. "HIF-1α Inhibition Improves Anti-Tumor Immunity and Promotes the Efficacy of Stereotactic Ablative Radiotherapy (SABR)" Cancers 14, no. 13: 3273.
https://doi.org/10.3390/cancers14133273
APA Style
Song, C. W., Kim, H., Cho, H., Kim, M.-S., Paek, S.-H., Park, H.-J., Griffin, R. J., Terezakis, S., & Cho, L. C.
(2022). HIF-1α Inhibition Improves Anti-Tumor Immunity and Promotes the Efficacy of Stereotactic Ablative Radiotherapy (SABR). Cancers, 14(13), 3273.
https://doi.org/10.3390/cancers14133273